PubHawk
Crit Rev Toxicol February 2025 PMID 39982125

A quantitative weight-of-evidence review of preclinical studies examining the potential developmental neurotoxicity of acetaminophen.

Daniel G Kougias, Evren Atillasoy, Michael D Southall, Anthony R Scialli, Sadaff Ejaz, Christopher Chu, Bamidele O Jeminiwa, Andrey Massarsky, Kenneth M Unice, Tammi H Schaeffer, Michael Kovochich

Full text PDF Download social card

Mentions

4
Peak: 4 in Sep 2025
across 3 sources since Sep 2025

Extended reach

116,154
potential audience

Total likes

0

Video views

2

Mentions per month

Sep 2025

All 4 dated mentions so far are from Sep 2025.

Where it's discussed

  • YouTube2 videos
  • X / Twitter1 posts
  • Bluesky1 posts

AI synopsis

What people are saying

The discussions highlight the study's rigorous use of a quantitative weight-of-evidence approach, with comments such as 'well designed study' and 'no consistent evidence of adverse effects,' indicating both respect for the methodology and an emphasis on safety conclusions. The tone is analytical and measured, emphasizing scientific validation rather than alarm or skepticism.

AgreementModerate agreement

Most discussions acknowledge the study's rigorous approach and conclude it supports safety, as seen in the comment about the well-designed study confirming no consistent adverse effects.

InterestModerate interest

The discussions show moderate interest, with participants interested in the scientific findings and implications for public health, but without highly emotional or provocative language.

EngagementModerate engagement

Participants show some engagement by referencing specific details like the study design and findings, though they do not delve deeply into methodological critique or broader debates.

ImpactModerate impact

The discussion suggests the study could influence perceptions of acetaminophen's safety, but the overall tone remains cautious and focused on confirmation rather than revolution in understanding.

Abstract in brief

  • This study uses a detailed quantitative weight-of-evidence (QWoE) approach to review preclinical research on whether acetaminophen (paracetamol) can cause developmental neurotoxicity, especially related to behavioral conditions like autism and ADHD.
  • The QWoE framework evaluates studies based on factors like experimental design, data reliability, and biological relevance, considering both outcomes like behavior changes and systemic toxicity, to determine the potential risks of acetaminophen exposure during development.
  • Analyzing 34 studies across multiple behavioral endpoints resulted in 188 entries, examining effects such as social behavior, hyperactivity, and impulsivity, but the review aims to clarify the evidence regarding acetaminophen's neurodevelopmental safety.
Read the full abstract

Top posts

Most liked on X and Bluesky
Xavier Tello, MD
@StratCons · X

@marthae050296 https://t.co/oeTucC4mCO

Sep 27, 2025 · 116,153 followers View post →
donotbelievereps.bsky.social
@donotbelievereps.bsky.social · Bluesky

A well designed study using quantitative weight-of-evidence review shows that the "in vivo data demonstrates no consistent evidence of adverse effects following developmental exposure to acetaminophen..." pubmed.ncbi.nlm.nih.gov/39982125/

Sep 23, 2025 View post →

All mentions

Xavier Tello, MD
@StratCons · X

@marthae050296 https://t.co/oeTucC4mCO

Sep 27, 2025 · 116,153 followers View post →
donotbelievereps.bsky.social
@donotbelievereps.bsky.social · Bluesky

A well designed study using quantitative weight-of-evidence review shows that the "in vivo data demonstrates no consistent evidence of adverse effects following developmental exposure to acetaminophen..." pubmed.ncbi.nlm.nih.gov/39982125/

Sep 23, 2025 View post →